Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes.

Gori N, Galluzzo M, Ippoliti E, Ambrosio B, Antonelli E, Capo A, Chello C, Mariano M, Martina E, Moretta G, Mortato E, Magnanimi LM, Skroza N, Amerio P, Campanati A, Duca ED, De Pità O, Esposito M, Fargnoli MC, Stingeni L, Tolino E, Di Nardo L, Peris K

Open source

DOI: 10.1177/17103568261489007
Published: 2026 Sep 23
Container: Dermatitis : contact, atopic, occupational, drug
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17103568261489007,
  title = {Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes.},
  author = {Gori N and Galluzzo M and Ippoliti E and Ambrosio B and Antonelli E and Capo A and Chello C and Mariano M and Martina E and Moretta G and Mortato E and Magnanimi LM and Skroza N and Amerio P and Campanati A and Duca ED and De Pità O and Esposito M and Fargnoli MC and Stingeni L and Tolino E and Di Nardo L and Peris K},
  year = {2026},
  journal = {Dermatitis : contact, atopic, occupational, drug},
  doi = {10.1177/17103568261489007},
  url = {https://doi.org/10.1177/17103568261489007}
}

RIS

TY  - JOUR
TI  - Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes.
AU  - Gori N
AU  - Galluzzo M
AU  - Ippoliti E
AU  - Ambrosio B
AU  - Antonelli E
AU  - Capo A
AU  - Chello C
AU  - Mariano M
AU  - Martina E
AU  - Moretta G
AU  - Mortato E
AU  - Magnanimi LM
AU  - Skroza N
AU  - Amerio P
AU  - Campanati A
AU  - Duca ED
AU  - De Pità O
AU  - Esposito M
AU  - Fargnoli MC
AU  - Stingeni L
AU  - Tolino E
AU  - Di Nardo L
AU  - Peris K
PY  - 2026
JO  - Dermatitis : contact, atopic, occupational, drug
DO  - 10.1177/17103568261489007
UR  - https://doi.org/10.1177/17103568261489007
ER  -

APA

N, G., M, G., E, I., B, A., E, A., A, C., C, C., M, M., E, M., G, M., E, M., LM, M., N, S., P, A., A, C., ED, D., O, D. P., M, E., MC, F., L, S., E, T., L, D. N., & K, P. (2026). Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes.. Dermatitis : contact, atopic, occupational, drug. https://doi.org/10.1177/17103568261489007

Source records

pubmed · retrieved 2026-09-25T06:52:22.722Z